T1	Participants 102 124	chronic schizophrenia.
T2	Participants 241 281	chronic schizophrenia in-patients (n=35)
T3	Participants 341 349	Patients
T4	Participants 363 393	stable antipsychotic treatment
T5	Participants 1446 1463	chronic patients.
